CD13 Antigens - CISMeF

Preferred Label : CD13 Antigens;

MeSH definition : Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.;

MeSH synonym : alanine aminopeptidase; alanyl aminopeptidase; aminopeptidase m; antigen, cd13; cd13 antigen; Aminopeptidase N; membrane alanyl aminopeptidase; Antigens, CD13; ANPEP Protein; Protein, ANPEP;

CISMeF synonym : m, aminopeptidase;

MeSH hyponym : amino-oligopeptidase; aminooligopeptidase;

CISMeF hyponym : EC 3.4.11.2;

MeSH Related Number : aminooligopeptidase; 9054-63-1 (CAS RN); EC 3.4.11.2;

Registry Number MeSH : EC 3.4.11.2;

Related CAS MeSH : EC 3.4.11.2 (Aminooligopeptidase);

Wikipedia link : https://en.wikipedia.org/wiki/Cd13 antigens;

Is substance : O;

UNII : EC 3.4.11.2;

Details

Origin ID

D018826;

UMLS CUI

C0054943;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Aminopeptidase N [NCIt concept]
- Lymphocyte antigen CD13 (substance) [SNOMED CT concept]
- microsomal aminopeptidase [SNOMED Notion]
Indexing information
- 2(S)-benzyl-3-hydroxy(1'(R)-aminoethyl)phosphinylpropanoyl-L-3-iodotyrosine [MeSH Supplementary Concept]
- 2-amino-4-methylsulfonyl butane thiol [MeSH Supplementary Concept]
- 2-amino-N-(1-(2-(hydroxyamino)-2-oxoethyl)-2,5-dioxopyrrolidin-3-yl)-3-phenylpropanamide [MeSH Supplementary Concept]
- 2-amino-N-(1-(2-amino-3-(4-aminophenyl)-3-hydroxypropylamino)-1-oxo-3-phenylpropan-2-yl)-4-methylpentanamide [MeSH Supplementary Concept]
- 2-benzyl-3-(hydroxy(1'-aminoethyl)phosphinyl)propanoyltyrosine [MeSH Supplementary Concept]
- 3-nitro-2-(2-nitrophenyl)-4-oxo-4H-1-benzopyran-8-acetic acid [MeSH Supplementary Concept]
- LB-4b compound [MeSH Supplementary Concept]
- LYP compound [MeSH Supplementary Concept]
- MR 387A [MeSH Supplementary Concept]
- MR 387B [MeSH Supplementary Concept]
- N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide [MeSH Supplementary Concept]
- leuhistin [MeSH Supplementary Concept]
- phebestin [MeSH Supplementary Concept]
Record concept(s)
- CD13 Antigens [MeSH concept]
- aminooligopeptidase [MeSH concept]
Related MeSH Supplementary Concept(s)
- H11 protein, haemonchus contortus [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- Alanine aminopeptidase [LOINC component]
- CD13 [LOINC component]
- CD13 Ag [LOINC component]
- Lymphocyte antigen CD13 (substance) [SNOMED CT concept]
- lymphocyte antigen cd13 [SNOMED Notion]
- microsomal aminopeptidase [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients